SC 13G/A 1 formsc13ga.htm

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

SCHEDULE 13G

 

Under the Securities Exchange Act of 1934

(Amendment No. 2)*

 

QSAM Biosciences, Inc.

(Name of Issuer)

 

Common Stock par value of $.0001 per share

(Title of Class of Securities)

 

74738N103

(CUSIP Number)

 

December 31, 2023

(Date of Event Which Requires Filing of this Statement)

 

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

 

☐ Rule 13d-1(b)

☒ Rule 13d-1(c)

☐ Rule 13d-1(d)

 

*The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

 

The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 

 

 

 
Schedule 13G/APage 2 of 7

 

CUSIP No. 74738N103

 

     
  1. Names of Reporting Persons.
    I.R.S. Identification Nos. of above persons (entities only).
    GSB Holdings, Inc.

 

     
  2. Check the Appropriate Box if a Member of a Group (See Instructions)
    (a) ☐
    (b) ☐

 

     
  3. SEC Use Only

 

     
  4. Citizenship or Place of Organization: Delaware
     

Number of

Shares

Beneficially

Owned by

Each

Reporting

Person With:

  
5. Sole Voting Power: 621,744
   
   
6. Shared Voting Power: 0
   
   
7. Sole Dispositive Power: 621,744
   
   
8. Shared Dispositive Power: 0
   

     
  9. Aggregate Amount Beneficially Owned by Each Reporting Person: 621,744

 

     
  10. Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) ☐

 

     
  11. Percent of Class Represented by Amount in Row (9): 13.9%

 

 

 

  12. Type of Reporting Persons (See Instructions): CO
     

 

 
Schedule 13G/APage 3 of 7

 

CUSIP No. 74738N103

 

     
  1. Names of Reporting Persons.
    I.R.S. Identification Nos. of above persons (entities only).
    David Howard Clarke

 

     
  2. Check the Appropriate Box if a Member of a Group (See Instructions)
    (a) ☐
    (b) ☒

 

     
  3. SEC Use Only

 

     
  4. Citizenship or Place of Organization: United States of America

 

Number of

Shares

Beneficially

Owned by

Each

Reporting

Person With:

  
5. Sole Voting Power: 733,972
   
   
6. Shared Voting Power: 0
   
   
7. Sole Dispositive Power: 733,972
   
   
8. Shared Dispositive Power: 0
   

     
  9. Aggregate Amount Beneficially Owned by Each Reporting Person: 733,972

 

     
  10. Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) ☐

 

     
  11. Percent of Class Represented by Amount in Row (9): 16.5%

 

 

 

  12. Type of Reporting Persons (See Instructions): IN
     

 

 
Schedule 13G/APage 4 of 7

 

Item 1. (a) Name of Issuer: QSAM Biosciences, Inc.

 

Item 1. (b) Address of Issuer’s Principal Executive Offices: 9442 Capital of Texas Hwy N, Plaza 1, Suite 500, Austin, TX 78759

 

Item 2. (a) Name of Person Filing:

 

This Schedule 13G/A is being filed by GSB Holdings, Inc. (“GSB Holdings”) and David Howard Clarke (“David Howard Clarke” or “Mr. Clarke”) with regard to their holdings of common stock of QSAM Biosciences, Inc., a Delaware corporation. Mr. Clarke, Vice President and director of GSB Holdings, makes all major decisions on behalf of GSB Holdings, including investment decisions. The power to vote and dispose or direct the disposition of securities on behalf of GSB Holdings is vested in Mr. Clarke.

 

Item 2. (b) Address of Principal Business Office or, if none, Residence:

 

The principal business address of each of the Reporting Persons is 14179 Laurel Trail, Wellington, FL 33414.

 

Item 2. (c) Citizenship:

 

GSB Holdings, Inc. is incorporated as a corporation in the state of Delaware. David Howard Clarke is a citizen of the United States of America.

 

Item 2. (d) Title of Class of Securities: Common Stock

 

Item 2. (e) CUSIP Number: 74738N103

 

 
Schedule 13G/APage 5 of 7

 

Item 3. If this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a: Not applicable

 

Item 4. Ownership

 

Reporting Person  Amount Beneficially Owned   Percent of Class (3)   Sole Power to Vote or to Direct the Vote   Shared Power to Vote or to Direct the Vote   Sole Power to Dispose or to Direct the Disposition of   Shared Power to Dispose or to Direct the Disposition of 
GSB Holdings, Inc.   621,744    13.9%   621,744        -    621,744          - 
David Howard Clarke(1)   733,972(2)   16.5%   733,972    -    733,972    - 

 

(1)Aside from shares of common stock held by David Howard Clarke in his personal capacity, Mr. Clarke possesses voting and dispositive power over shares held of record by Bounty Hunter, LLC, in his capacity as its managing director and certain shares held of record by his grandson, Mr. August Gaines. Mr. Clarke disclaims beneficial ownership of such securities for any other purposes than Section 13(d) of the Securities Exchange Act of 1934.

(2)Includes 40,222 shares held by Mr. Clarke in his personal capacity.

(3)The percentage is calculated based upon total outstanding shares of 4,445,469 as of February 6, 2024, as provided by QSAM Biosciences, Inc.

 

Item 5. Ownership of Five Percent or Less of a Class

 

Not applicable.

 

Item 6. Ownership of More than Five Percent on Behalf of Another Person

 

Not applicable.

 

Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company or Control Person

 

Not applicable.

 

Item 8. Identification and Classification of Members of the Group

 

Not applicable.

 

Item 9. Notice of Dissolution of Group

 

Not applicable.

 

Item 10. Certifications

 

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

 

 
Schedule 13G/APage 6 of 7

 

SIGNATURE

 

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

 

Dated: February 15, 2024

 

  GSB Holdings, Inc.
     
    /s/ David Howard Clarke
  Name: David Howard Clarke
  Title: Vice President & Director
     
  David Howard Clarke
     
  By: /s/ David Howard Clarke

 

 
Schedule 13G/APage 7 of 7

 

Joint Filing Agreement Pursuant to Rule 13d-1

 

This agreement is made pursuant to Rule 13d-1(k)(1) under the Securities and Exchange Act of 1934 (the “Act”) by and among the parties listed below, each referred to herein as a “Joint Filer”. The Joint Filers agree that a statement of beneficial ownership as required by Sections 13(g) or 13(d) of the Act and the Rules thereunder may be filed on each of their behalf on Schedule 13G or Schedule 13D, as appropriate, and that said joint filing may thereafter be amended by further joint filings. The Joint Filers state that they each satisfy the requirements for making a joint filing under Rule 13d-1.

 

Dated: February 15, 2024

 

  GSB Holdings, Inc.
     
    /s/ David Howard Clarke
  Name: David Howard Clarke
  Title: Vice President & Director
     
  David Howard Clarke
     
  By: /s/ David Howard Clarke